Levine Cancer Institute - Charlotte — Charlotte, North Carolina

Levine Cancer Institute - Charlotte is a clinical research site located in Charlotte, North Carolina, United States 28204-2990.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Levine Cancer Institute - Charlotte has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.

Sponsors: Pierre Fabre Medicament, QED Therapeutics, a BridgeBio company.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Levine Cancer Institute - Charlotte?

Levine Cancer Institute - Charlotte has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Levine Cancer Institute - Charlotte conducted?

Levine Cancer Institute - Charlotte has 2 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.

Is Levine Cancer Institute - Charlotte accredited by Crixeo Health?

Levine Cancer Institute - Charlotte has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Levine Cancer Institute - Charlotte?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.